There may be widely recommended medicines for treating opioid addiction, but one-third of primary care physicians believe the treatments are no more effective or safe than other approaches, such as counseling or a 12-step recovery program, according to a new survey.

Of three treatments that are approved by the Food and Drug Administration for combating what is known clinically as opioid use disorder, just 7.6% of physicians reported prescribing buprenorphine and only 4% prescribed injectable naltrexone. (A third medicine, methadone, can be only dispensed for treating addiction as part of specialty treatment programs).

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • I had a roommate who became addicted to heroin while in high school. He went to various rehab programs, and at age 25 was attending regular Alcoholics Anonymous (A.A.) in effort to stay clean of heroin. One of the major points he wanted me to know about his past experiences was to avoid taking Suboxone (Buprenorphine / Naloxone). He said it was a HORRIBLE drug and that the withdrawal from Suboxone was 10x worse than the withdrawal from heroin. I will never forget that conversation with my old roommate.

    The bottom of page 37 in the report that you reference, “Medications for Opioid Use Disorder Save Lives”, states that “buprenorphine’s withdrawal syndrome may be less severe” than methadone or heroin withdrawal; but I have to take such strong issue with that statement based on my friends anecdote.

    The report later goes on to say roughly that particular drugs and drug doses are more, or less, suited for different types of people and that more research/focus needed to go into this area. I agree with this point and think that pharmacology can have its place in drug abuse treatment. However, high standards in this area should be in place to prevent people from transferring one addiction (heroin) to another addiction (buprenorphine / nalaxone). I do not blame primary care physicians or other medical providers for not being comfortable with prescribing addictive drugs like suboxone. Especially not after the same or similar drug companies recommended PCPs to overprescribe opioids, which is what originally introduced that person to the effects of opioids.

Comments are closed.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy